Tempest Therapeutics, Inc. — Director's Dealing 2013

Sep 12, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OvaScience, Inc. (OVAS)
CIK: 0001544227
Period of Report: 2013-09-11

Reporting Person: ALDRICH RICHARD (Director, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-09-11	Common Stock	P	4850	$10.54	Acquired	4850	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	526445	Direct
Common Stock	175481	Indirect
Common Stock	3720571	Indirect

Footnotes

F1: The trustee of the Richard H. Aldrich 2005 Revocable Trust is the reporting person and he exercises sole voting and investment power over the shares of record held by the trust.

F2: The trustee of the Richard H. Aldrich Irrevocable Trust of 2011 is the reporting person's spouse, Nichole Aldrich, and she exercises sole voting and investment power over the shares of record held by the trust.

F3: Longwood Fund GP, LLC is the general partner of Longwood Fund, LP. Voting and investment power with respect to the shares held by Longwood Fund, LP are vested in Richard Aldrich, Michelle Dipp, M.D., Ph.D. and Christoph Westphal, M.D., Ph.D. (collectively, the "Managers"), the managers of Longwood Fund GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund, LP, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose.